Lacto-N-fucopentaose I (LNFPI) 是一种人母乳寡糖 (HMO),具有抗病毒和抗菌活性。Lacto-N-fucopentaose I 通过减少衣壳蛋白 VP1 来阻断病毒吸附,增加 CDK2、减少 cyclin E 恢复细胞周期 S 期的阻滞。Lacto-N-fucopentaose I 抑制病毒感染的细胞凋亡 (apoptosis)。Lacto-N-fucopentaose I 也抑制 ROS 的产生。Lacto-N-fucopentaose I 还可以调节肠道菌群影响免疫系统发育。
Multiflorin A 是传统草本泻药郁李仁 (Pruni semen) 的一种具有口服活性的成分。Multiflorin A 可抑制芳香化酶 (aromatase) 的酶活性,其 IC50 为 15.5 μM。Multiflorin A 还可抑制醌还原酶 2 (QR2) 和 COX-2 酶。Multiflorin A 具有泻下活性,可降低小鼠餐后血糖。Multiflorin A 可调控肠道葡萄糖转运蛋白、紧密连接蛋白和水通道蛋白,重塑肠道菌群并改变粪便代谢物。Multiflorin A 可用于便秘和糖尿病的相关研究。
苍术苷 A
Atractyloside A 是一种具有口服活性的 TLR4/MyD88/NF-κB 信号通路抑制剂,也是线粒体通透性转换孔 (MPTP) 开放促进剂。Atractyloside A 可干扰 TLR4/MyD88/NF-κB 通路的激活,从而抑制肠道炎症反应。Atractyloside A 可逆转黏蛋白合成障碍、改善肠道屏障完整性,并通过改变肠道菌群组成恢复稳态。Atractyloside A 可用于脾虚泄泻及心肌损伤相关研究。
3-Indolepropionic acid (Standard) 是 3-Indolepropionic acid 的分析标准品。本产品用于研究及分析应用。3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease.
Theasinensin C 是一种口服有效的肾素抑制剂和菌群调节剂,对肾素活性的 IC50 为 40.21 μM。Theasinensin C 可在肠道菌群中选择性富集嗜黏蛋白阿克曼菌 (Akkermansia muciniphila),增强其介导的黏蛋白 PTS 结构域水解,驱动管腔谷氨酰胺与丝氨酸积累,并调控肠-肾-肝谷氨酰胺/丝氨酸代谢信号通路以促进肌酸生物合成。Theasinensin C 可改善认知功能、减少促炎细胞因子、缓解神经病理改变并恢复肠道屏障完整性。Theasinensin C 可用于高血压及高果糖饮食诱导的神经炎症相关研究。
麦冬皂苷D
Ophiopogonin D 是可以从麦冬 (Ophiopogon japonicus) 的块茎中分离的,是一种罕见的天然存在的 C29 甾体糖苷。Ophiopogonin D 是 CYP2J3 诱导剂,其通过增加人脐静脉内皮细胞 (HUVECs) 中 CYP2J2/EETs 和 PPARα 的表达,显着抑制 Ang II 诱导的 NF-κB 核转位,IκBα 下调,细胞内 Ca2+ 过载和促炎细胞因子的激活。Ophiopogonin D 能抑制 RAW264.7 细胞的破骨细胞分化。Ophiopogonin D 作为抗氧化剂,在过氧化氢 (H2O2) 诱导的内皮损伤中具有保护作用。Ophiopogonin D 能阻断 ERK 信号级联。Ophiopogonin D 可缓解高脂饮食引起的代谢综合征,并改变小鼠肠道菌群的结构。Ophiopogonin D 已被用于炎症、代谢和心血管疾病。
Iron (II) sulfate hydrate 是一种具有口服活性的亚铁盐,可作为铁补充剂,在水中易被氧化为三价铁。Iron (II) sulfate hydrate 可诱导癌细胞发生凋亡形态学改变,并在大鼠中促进剂量依赖性铁蓄积。Iron (II) sulfate hydrate 可用于白血病、乳腺癌、缺铁症、贫血和不宁腿综合征的相关研究。
麦冬皂苷D (标准品)
Ophiopogonin D (Standard) 是 Ophiopogonin D 的分析标准品。本产品用于研究及分析应用。Ophiopogonin D 是可以从麦冬 (Ophiopogon japonicus) 的块茎中分离的,是一种罕见的天然存在的 C29 甾体糖苷。Ophiopogonin D 是 CYP2J3 诱导剂,其通过增加人脐静脉内皮细胞 (HUVECs) 中 CYP2J2/EETs 和 PPARα 的表达,显着抑制 Ang II 诱导的 NF-κB 核转位,IκBα 下调,细胞内 Ca2+ 过载和促炎细胞因子的激活。Ophiopogonin D 能抑制 RAW264.7 细胞的破骨细胞分化。Ophiopogonin D 作为抗氧化剂,在过氧化氢 (H2O2) 诱导的内皮损伤中具有保护作用。Ophiopogonin D 能阻断 ERK 信号级联。Ophiopogonin D 可缓解高脂饮食引起的代谢综合征,并改变小鼠肠道菌群的结构。Ophiopogonin D 已被用于炎症、代谢和心血管疾病。
莱苞迪苷D
Rebaudioside D 是一种口服有效的甜味剂,靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢,降低脂肪酸与胆固醇的合成速率,具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化,并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路,上调回肠有机溶质转运蛋白 α 的基因表达,下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能,也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
莱苞迪苷D (标准品)
Rebaudioside D (Standard) 是 Rebaudioside D 的分析标准品。本产品用于研究及分析应用。Rebaudioside D 是一种口服有效的甜味剂,靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢,降低脂肪酸与胆固醇的合成速率,具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化,并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路,上调回肠有机溶质转运蛋白 α 的基因表达,下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能,也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
麦冬皂苷D
Ophiopogonin D 是可以从麦冬 (Ophiopogon japonicus) 的块茎中分离的,是一种罕见的天然存在的 C29 甾体糖苷。Ophiopogonin D 是 CYP2J3 诱导剂,其通过增加人脐静脉内皮细胞 (HUVECs) 中 CYP2J2/EETs 和 PPARα 的表达,显着抑制 Ang II 诱导的 NF-κB 核转位,IκBα 下调,细胞内 Ca2+ 过载和促炎细胞因子的激活。Ophiopogonin D 能抑制 RAW264.7 细胞的破骨细胞分化。Ophiopogonin D 作为抗氧化剂,在过氧化氢 (H2O2) 诱导的内皮损伤中具有保护作用。Ophiopogonin D 能阻断 ERK 信号级联。Ophiopogonin D 可缓解高脂饮食引起的代谢综合征,并改变小鼠肠道菌群的结构。Ophiopogonin D 已被用于炎症、代谢和心血管疾病。
莱苞迪苷D
Rebaudioside D 是一种口服有效的甜味剂,靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢,降低脂肪酸与胆固醇的合成速率,具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化,并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路,上调回肠有机溶质转运蛋白 α 的基因表达,下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能,也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
Lacto-N-fucopentaose I (LNFPI) 是一种人母乳寡糖 (HMO),具有抗病毒和抗菌活性。Lacto-N-fucopentaose I 通过减少衣壳蛋白 VP1 来阻断病毒吸附,增加 CDK2、减少 cyclin E 恢复细胞周期 S 期的阻滞。Lacto-N-fucopentaose I 抑制病毒感染的细胞凋亡 (apoptosis)。Lacto-N-fucopentaose I 也抑制 ROS 的产生。Lacto-N-fucopentaose I 还可以调节肠道菌群影响免疫系统发育。
Multiflorin A 是传统草本泻药郁李仁 (Pruni semen) 的一种具有口服活性的成分。Multiflorin A 可抑制芳香化酶 (aromatase) 的酶活性,其 IC50 为 15.5 μM。Multiflorin A 还可抑制醌还原酶 2 (QR2) 和 COX-2 酶。Multiflorin A 具有泻下活性,可降低小鼠餐后血糖。Multiflorin A 可调控肠道葡萄糖转运蛋白、紧密连接蛋白和水通道蛋白,重塑肠道菌群并改变粪便代谢物。Multiflorin A 可用于便秘和糖尿病的相关研究。
苍术苷 A
Atractyloside A 是一种具有口服活性的 TLR4/MyD88/NF-κB 信号通路抑制剂,也是线粒体通透性转换孔 (MPTP) 开放促进剂。Atractyloside A 可干扰 TLR4/MyD88/NF-κB 通路的激活,从而抑制肠道炎症反应。Atractyloside A 可逆转黏蛋白合成障碍、改善肠道屏障完整性,并通过改变肠道菌群组成恢复稳态。Atractyloside A 可用于脾虚泄泻及心肌损伤相关研究。
3-Indolepropionic acid (Standard) 是 3-Indolepropionic acid 的分析标准品。本产品用于研究及分析应用。3-Indolepropionic acid is shown to be a powerful antioxidant and has potential in the treatment for Alzheimer’s disease.
麦冬皂苷D (标准品)
Ophiopogonin D (Standard) 是 Ophiopogonin D 的分析标准品。本产品用于研究及分析应用。Ophiopogonin D 是可以从麦冬 (Ophiopogon japonicus) 的块茎中分离的,是一种罕见的天然存在的 C29 甾体糖苷。Ophiopogonin D 是 CYP2J3 诱导剂,其通过增加人脐静脉内皮细胞 (HUVECs) 中 CYP2J2/EETs 和 PPARα 的表达,显着抑制 Ang II 诱导的 NF-κB 核转位,IκBα 下调,细胞内 Ca2+ 过载和促炎细胞因子的激活。Ophiopogonin D 能抑制 RAW264.7 细胞的破骨细胞分化。Ophiopogonin D 作为抗氧化剂,在过氧化氢 (H2O2) 诱导的内皮损伤中具有保护作用。Ophiopogonin D 能阻断 ERK 信号级联。Ophiopogonin D 可缓解高脂饮食引起的代谢综合征,并改变小鼠肠道菌群的结构。Ophiopogonin D 已被用于炎症、代谢和心血管疾病。
莱苞迪苷D (标准品)
Rebaudioside D (Standard) 是 Rebaudioside D 的分析标准品。本产品用于研究及分析应用。Rebaudioside D 是一种口服有效的甜味剂,靶向激活 FXR、调节 Acetyl-CoA Carboxylase 和抑制 3-hydroxy-3-methylglutaryl-CoA reductase。Rebaudioside D 调控胆汁酸稳态与脂质代谢,降低脂肪酸与胆固醇的合成速率,具有抗脂肪生成、保肝、抗脂肪变性、调节肠道菌群、增强次级胆汁酸代谢、抗内毒素、调控胆汁酸转运及抑制胆汁酸外排等多重作用。Rebaudioside D 还减少体重增长、内脏脂肪堆积、肝脏甘油三酯与胆固醇蓄积、肝脏脂质过氧化,并降低循环中脂多糖结合蛋白的水平。Rebaudioside D 还增强肠道细菌次级胆汁酸代谢通路,上调回肠有机溶质转运蛋白 α 的基因表达,下调肝脏胆盐输出泵蛋白的基因表达。Rebaudioside D 不影响葡萄糖稳态、改变总热量摄入或粪便能量排泄、诱导体重增加、加重肥胖、促进肝脏脂肪变性、损伤棕色脂肪组织功能,也不会改变骨骼肌代谢相关蛋白。Rebaudioside D 可用于饮食诱导肥胖及肥胖相关研究。
Theasinensin C 是一种口服有效的肾素抑制剂和菌群调节剂,对肾素活性的 IC50 为 40.21 μM。Theasinensin C 可在肠道菌群中选择性富集嗜黏蛋白阿克曼菌 (Akkermansia muciniphila),增强其介导的黏蛋白 PTS 结构域水解,驱动管腔谷氨酰胺与丝氨酸积累,并调控肠-肾-肝谷氨酰胺/丝氨酸代谢信号通路以促进肌酸生物合成。Theasinensin C 可改善认知功能、减少促炎细胞因子、缓解神经病理改变并恢复肠道屏障完整性。Theasinensin C 可用于高血压及高果糖饮食诱导的神经炎症相关研究。
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.